Basel Medical Group Ltd
BMGL- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0002004489
No open-market purchases or sales by Basel Medical Group Ltd insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $3.44K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −2 vs. previous quarter
- 2
- 13F valueReported value at the end of Q2 2026
- $3.44K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding BMGL, Q2 2026
No superinvestor reported holding BMGL at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Basel Medical Group Ltd insiders from Form 4, newest first.
No open-market purchases or sales by Basel Medical Group Ltd insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Basel Medical Group Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 495 | $3.44K | 0.00% | −12,561−96.2% | Reduced |
| Coston, McIsaac & Partners | 4 | $0 | 0.00% | −46−92.0% | Reduced |
Holders of 5% or more of BMGL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Basel Medical Group Ltd.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Rainforest Capital VCC | 13G | 54.20%10.2M shares | New | Apr 30, 20251 filing | Apr 30, 2025 | SEC |